
Ceftrafit S 250mg/125mg Injection
Marketer
Biocell Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftrafit S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this medication requires adherence to the prescribed schedule; premature cessation may compromise efficacy. Complete the full course, even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions such as rash, itching, swelling, or respiratory distress. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration support recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Ceftrafit S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Ceftrafit S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftrafit S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftrafit S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftrafit S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Ceftrafit S 250mg/125mg Injection works:
Ceftrafit S injection (250mg/125mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. Sulbactam counters bacterial resistance mechanisms, augmenting ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceftrafit S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftrafit S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Ceftrafit S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Ceftrafit S 250mg/125mg Injection could induce drowsiness, visual impairment, or dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ceftrafit S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Ceftrafit S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ceftrafit S 250mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftrafit S 250mg/125mg Injection :
Omitting a scheduled dose of Ceftrafit S 250mg/125mg Injection warrants immediate physician consultation.
Facts to Know About Ceftrafit S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
